Morgan Stanley caused a stir on Tuesday when it put out a "bear case" scenario of $10. Now Citi is getting in on the act.Investingread more
Qualcomm unlawfully suppressed competition in the market for cellphone chips and used its dominant position to impose excessive licensing fees, a U.S. judged ruled.Technologyread more
Target's e-commerce sales also surged 42%, as shoppers increasingly turned to its curbside pickup service for online orders, something Amazon can't offer.Retailread more
Homeowners are taking advantage of lower interest rates, rushing to refinance their mortgages before rates potentially turn higher again.Real Estateread more
Lowe's shares plummeted 8% before the bell Wednesday after the company posted mixed fiscal first-quarter results and cut its forecast for the year, as higher costs weighed on...Retailread more
Department stores are being hung out to dry as Kohl's shares fall after earnings, but some experts still see opportunity in the space.Trading Nationread more
It may be years from visiting your neighborhood, but a walking robot is part of Ford's vision for how its autonomous vehicles will deliver packages.Technologyread more
Brazilian makeup brand Natura Cosmeticos agreed to buy Avon Products, according to two media reports early on Wednesday.Retailread more
Consumers in China are taking to social media to express their support for Huawei as the U.S. government looks to ramp up pressure on the Chinese smartphone maker.Technologyread more
Tensions between the two parties have heightened in recent months as the campaign for seats in the Brussels and Strasbourg-based parliament has crescendoed.Europe Politicsread more
St. Louis Federal Reserve President James Bullard expressed optimism that the United States and China will reach a deal to end their trade war.World Economyread more
Clorox Co.: "Clorox was down $5 today because interest rates went up. As interest rates keep going up, this stock will go down. It's one for one. That means when it gets to $140, buy, buy, buy!"
Sirius XM Holdings Inc.: "I have been behind this stock, literally, for $3 and a half and now I am starting to cool. I did not like the Pandora acquisition. You've got Tencent, you've got Spotify and now you have XM. No. It's too competitive for me. I'm now saying don't buy – that's a major change for me. "
New Relic Inc.: "This stock's ridiculous. It's come down. Remember, it's up 54 percent for the year, but it has come down mightily, and I've got to tell you, I'm getting real interested in [CEO] Lew Cirne's company. I think the stock in the $80s is a buy."
AbbVie Inc.: "I'm worried about ABBV. Why? Because there's a competitive product that's a biosimilar put out by [Johnson & Johnson]. I think that it may be time in this spike – and I think AbbVie spikes to $100 – to do a little schnitzel. I'm getting concerned. By the way, I'm telling club members of ActionAlertsPlus.com that JNJ is right here. "
Shotspotter Inc.: "We did a piece on it. We kind of liked it. It detects gunfire shots. We kind of think it's a pretty good situation."
Disclosure: Cramer's charitable trust owns shares of Johnson & Johnson.